| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |